Stay updated on Brigatinib Post Next-Gen ALK Inhibitors Clinical Trial
Sign up to get notified when there's something new on the Brigatinib Post Next-Gen ALK Inhibitors Clinical Trial page.

Latest updates to the Brigatinib Post Next-Gen ALK Inhibitors Clinical Trial page
- Check4 days agoChange DetectedThe page footer revision number was updated from v3.5.2 to v3.5.3, reflecting a site software/version change rather than a change to the study record content.SummaryDifference0.1%

- Check11 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check40 days agoChange DetectedThe site software revision was updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check47 days agoChange Detected- The revision label updated from v3.4.2 to v3.4.3. The page content otherwise remains unchanged.SummaryDifference0.1%

- Check75 days agoChange DetectedThe site updated to revision v3.4.2, and the previous notice about government funding and operating status was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check83 days agoChange DetectedA banner about a government funding lapse and operational status was added, with links to cc.nih.gov and opm.gov for updates, and the page version was updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Brigatinib Post Next-Gen ALK Inhibitors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Brigatinib Post Next-Gen ALK Inhibitors Clinical Trial page.